No Data
No Data
DongHua Testing Technology: 2024 Interim Performance Forecast
Donghua testing technology (300354.SZ) plans to distribute 1.28 yuan per 10 shares on July 3, after ex-rights and ex-dividend.
Donghua Testing Technology (300354.SZ) announced that the annual equity distribution in 2023 is planned to be distributed to all shareholders at a rate of 10 shares per...
DongHua Testing Technology Co. , Ltd.'s (SZSE:300354) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
DongHua Testing Technology (SZSE:300354) has had a rough three months with its share price down 26%. But if you pay close attention, you might gather that its strong financials could mean that the s
Insiders Were the Key Beneficiaries as DongHua Testing Technology Co. , Ltd.'s (SZSE:300354) Market Cap Rises to CN¥5.5b
Key Insights DongHua Testing Technology's significant insider ownership suggests inherent interests in company's expansion 57% of the business is held by the top 2 shareholders Institutions own 2
Donghua Test (300354.SZ): The product can be used to monitor the health of satellite launchers
Gelonghui, May 31丨An investor asked Donghua Test (300354.SZ) on the investor interactive platform, “In the domestic satellite Internet industry, does Donghua Test enter related fields and can it benefit from the rapid development of satellite Internet?” The company replied that the company's products can be used to monitor the health of satellite launchers, monitor signals such as vibration, strain, temperature, and noise at key positions of the launcher, and understand the overall health status of the launcher in real time.
Donghua Test (300354.SZ): The six-dimensional force sensor is in the small-batch trial production stage
Gelonghui May 31 丨 Some investors asked Donghua Test (300354.SZ) on the investor interactive platform, “What are the downstream application scenarios of the six-dimensional force sensor products produced by your company?” The company replied that the company's six-dimensional force sensor is in the small-batch trial production stage, and the company will fulfill its information disclosure obligations in strict accordance with regulations. Please pay attention to the company's subsequent announcements.
No Data